Abikem 250mg Tablet

Abikem 250mg Tablet

S4
PDF Leaflet Revision Date: 15 March 2022


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of metastatic castration-resistant prostate cancer.

Dosage (summary)

1,000 mg (four 250 mg tablets) once daily, taken without food.

Special Populations

  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation; may harm a developing fetus.

Key Drug Interactions

  • Avoid strong CYP3A4 inducers
  • Contraindicated with rifampicin

Contraindications

  • Hypersensitivity
  • Pregnancy
  • Moderate to severe hepatic impairment
  • Concomitant use with Ra-223

Common side effects

  • Fluid retention
  • Hypokalaemia
  • Hypertension
  • Increased liver enzymes

Counselling Points

  • Take at least 2 hours after eating
  • Monitor for signs of liver toxicity
  • Use condoms if sexually active with women of childbearing age

Serious warnings

  • May cause hypertension, hypokalaemia, fluid retention
  • Risk of hepatotoxicity

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Abikem 250mg Tablet
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW